Drug induced subacute dyskinesia
ICD-10 G24.01 is a billable code used to indicate a diagnosis of drug induced subacute dyskinesia.
Drug induced subacute dyskinesia is a movement disorder characterized by involuntary, erratic movements that can occur as a side effect of certain medications, particularly those that affect dopaminergic pathways in the brain. This condition is often associated with the use of antipsychotic medications, particularly first-generation antipsychotics, which can lead to extrapyramidal symptoms (EPS). Subacute dyskinesia typically manifests within days to weeks of starting or increasing the dosage of the offending drug. Symptoms may include abnormal facial movements, limb jerking, and other involuntary movements that can significantly impact a patient's quality of life. The pathophysiology involves an imbalance in the dopaminergic and cholinergic systems, leading to dysregulation of motor control. Patients with Parkinson's disease or other movement disorders may be particularly susceptible to developing drug-induced dyskinesia when treated with dopaminergic medications, as the introduction of these drugs can exacerbate underlying movement disorders. Accurate diagnosis and coding are essential for appropriate management and treatment adjustments.
Detailed documentation of neurological assessments, medication history, and symptomatology.
Patients presenting with new movement disorders after starting or adjusting dopaminergic medications.
Neurologists should document the specific medications and dosages, as well as any previous history of movement disorders.
Thorough documentation of psychiatric medications prescribed and their dosages.
Patients experiencing dyskinesia after initiation of antipsychotic treatment.
Psychiatrists should be aware of the potential for EPS and document any changes in medication regimens.
Used when evaluating a patient with drug-induced dyskinesia.
Document the patient's history, medication changes, and current symptoms.
Neurologists and psychiatrists should ensure comprehensive evaluations are documented.
Common medications include first-generation antipsychotics like haloperidol and certain antiemetics. Dopaminergic medications used in Parkinson's disease can also contribute to dyskinesia.
